J Neuropsychiatry Clin Neurosci 10:93-95, February 1998
© 1998 American Psychiatric Press, Inc.
Clinical and Research Report |
Use of Clozapine in 10 Mentally Retarded Adults
Randall D. Buzan, M.D.,
Steven L. Dubovsky, M.D.,
Diane Firestone, R.N., C.F.N.P. and
Earlene Dal Pozzo, M.D.
Received December 19, 1996; revised March 24, 1997; accepted March 27, 1997. From the Department of Psychiatry, University of Colorado School of Medicine, Denver, and Wheat Ridge Regional Center, Wheat Ridge, Colorado. Address correspondence to Dr. Buzan, University of Colorado School of Medicine, Campus Box C-270-50, 4200 E. Ninth Avenue, Denver, CO 80262.
The cost, side effect profile, and required weekly blood draws associated with clozapine may dissuade some clinicians from prescribing this atypical neuroleptic to mentally retarded patients. All publications on clozapine use in mentally retarded patients are reviewed and the treatment of 10 such patients is described, bringing the total number of published cases to 84. Clozapine is efficacious and well tolerated in this population and should be considered for those patients with psychosis or bipolar illness who are intolerant of or unresponsive to other agents.
Key Words: Clozapine • Mental Retardation • Wolff-Parkinson-White Syndrome
This article has been cited by other articles:
|
|
|
|
 
R Antochi, C Stavrakaki, and P C Emery
Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities
Postgrad. Med. J.,
March 1, 2003;
79(929):
139 - 146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Einfeld
Systematic management approach to pharmacotherapy for people with learning disabilities
Adv. Psychiatr. Treat.,
January 1, 2001;
7(1):
43 - 49.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1998
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
